chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.75
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Patient was here for their well child exam. They had received a Moderna Monovalent vaccine in March of 2023. At their May appointment they were given 0.2ml from the pink cap Moderna vial which was incorrect. They should have received a 0.25 ml dose from the blue cap Moderna.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Breathing-related sleep disorder, Facial paresis, Obstructive sleep apnoea syndrome, Transient ischaemic attack
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE TRANSIENT CEREBRAL ISCHEMIA BREATHING RELATED SLEEP DISORDER OBSTRUCTIVE SLEEP APNEA RIGHT BELLS PALSY RIGHT FACIAL MUSCLE WEAKNESS
Age: 0.17
Sex: M
Vaccine: PNC20
Symptoms: No adverse event
Clinical narrative: Patient may have received two Prevnar#1 and no Vaxlelis #1 during their 2 months appointment. No adverse outcome reported by mother at home. Checked in 1 month post vaccination, baby still doing well.
Age: 44.0
Sex: F
Vaccine: MMRV
Symptoms: Wrong product administered
Clinical narrative: Pt. was given a MMRV when she was only due for a MMR. This means she got a 3rd does for Varicella.  She states she has not reacting after given the wrong vaccination. This event happened on 06/02/2023 in the afternoon.
Age: 38.0
Sex: F
Vaccine: HPV9
Symptoms: Injection site cellulitis, Vaccine positive rechallenge
Clinical narrative: Cellulitis of right deltoid 3 weeks post injection. This occurred with second dose as well but was not considered a reaction at that time.
Age: 4.0
Sex: F
Vaccine: MMRV
Symptoms: Injection site erythema, Injection site inflammation, Injection site swelling
Clinical narrative: Patient presented to clinic with mom. Patient seen and evaluated. Per mom, patient received vaccines on 6/6/2023. She developed a red bump at site of injection that has not gone away. No fevers. Normal po intake and activity. Otherwise acting normally. Patient in NAD and very social. Examination revealed a 2 X 3 cm erythematous raised area. It is not warm and does not seem to be tender to exam based on patient's response to it being touched. There is no fluctuance. There is no inguinal LAD. Lungs are CTA with good air movement. Exam consistent with localized vaccine reaction. Conservative therapy recommended with instructions to seek care if it does not improve within 7-10 days, or any worsening symptoms. Staff instructed to report the reaction through VARS
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Myocarditis, Pericarditis
Clinical narrative: ACUTE PERICARDITIS, UNSPECIFIED  MYOCARDITIS
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Abnormal sensation in eye, Arthralgia, Back pain, Chills, Cough
Clinical narrative: Fever (100+), chills, body aches (arms, shoulders, back), fatigue, feverish eyes, coughing, congestion, headache, shortness of breath, nausea
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dyspnoea, Fatigue, Headache, Nausea, Pain in extremity
Clinical narrative: Fever (100+), chills, body aches (arms, shoulders, back), fatigue, feverish eyes, coughing, congestion, headache, shortness of breath, nausea
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pyrexia, Respiratory tract congestion
Clinical narrative: Fever (100+), chills, body aches (arms, shoulders, back), fatigue, feverish eyes, coughing, congestion, headache, shortness of breath, nausea
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: HYPOTENSION 11/26/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Headache, Nausea, Neuralgia, Pain
Clinical narrative: Terrible headache, fatigue, nerve pain, nausea (threw up stomach acid) and body aches
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Vomiting
Clinical narrative: Terrible headache, fatigue, nerve pain, nausea (threw up stomach acid) and body aches
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test abnormal, Erythema, Lymphomatoid papulosis, Skin lesion
Clinical narrative: AE:  Lymphomatoid Papulosis Treatment:  Clobetasol Outcomes:  As many as 30 small red lesions on arms, shoulders and a few on legs behind knee; they come and go in different locations (always on arms and legs); still have several as of today 6.14.23 (started around May 2021)
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: ACUTE DVT OF LEFT CALF, UNSPECIFIED VEIN
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Deep vein thrombosis
Clinical narrative: I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 4/12/2023 ABDOMINAL PAIN
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood test abnormal, Computerised tomogram head normal, Headache, Mobility decreased, Pyrexia
Clinical narrative: In May 2023, after dose 6, I had severe headaches and fever that led me to be bed ridden for an entire day.  My headaches continued and I went to the walk-in clinic, and they sent me to the emergency department.  They ran tests and found abnormalities in urine and blood.  I have visited with an internal medicine doctor and and do not have results of tests at this time.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Urine analysis abnormal, X-ray normal
Clinical narrative: In May 2023, after dose 6, I had severe headaches and fever that led me to be bed ridden for an entire day.  My headaches continued and I went to the walk-in clinic, and they sent me to the emergency department.  They ran tests and found abnormalities in urine and blood.  I have visited with an internal medicine doctor and and do not have results of tests at this time.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Aortic arteriosclerosis, Chronic respiratory failure, Respiratory failure
Clinical narrative: J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/5/2023 ATHEROSCLEROSIS OF AORTA J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/5/2023 CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/5/2023 PREOP EXAM
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Pulmonary embolism
Clinical narrative: ACUTE DVT OF RIGHT PERONEAL VEIN ACUTE PULMONARY EMBOLISM
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Myalgia
Clinical narrative: Pt called to report and discuss muscle pain with onset later in the evening of 6/13/2023 after receiving her second dose of Shingrix. Pt reports the muscle pain/aches were more significant and noticeable compared to the first dose. Pt denies any other symptoms at the time of our discussion (no swelling, no SOB, no redness/rash, no mental status changes, etc.) Pt main concern was that the muscle aches will prevent her from accomplishing some of her "to do" list items today/this week.
Age: 18.0
Sex: M
Vaccine: MMR
Symptoms: Wrong product administered
Clinical narrative: Received MMR vaccine instead of the Varicella vaccine that was requested. MMR immunity was already up-to-date. Unknown adverse effects of giving extra vaccine at this time.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 4/21/21 lot# EW0162;  Pfizer 5/12/21 lot# EW0172;  Pfizer 12/15/21 lot# 33038D
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 12/6/21 lot# 031H21A;  Moderna 1/3/22 lot# 041J21A
Age: 81.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: The patients injection site was sore, hot to the touch, bumpy, swollen, and red in color
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 3/8/21 lot# 037K20A;  Moderna 4/9/21 lot# 027L20A ; Moderna 12/2/21 lot# 034F21A
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram cerebral normal, Anticoagulant therapy, Arteriogram carotid abnormal, Atrial flutter, Bradycardia
Clinical narrative: 69-year-old male with history of CAD s/p MI 6/2/2022 (unable to stent LAD -- recommended DAPT for one year, then aspirin only), HFrEF (last EF 30%), HTN, CKD 3, OSA on CPAP, hypothyroidism, who presented with acute onset lightheadedness and slurred speech while exerting himself on a ladder at 12PM on 6/7.  On arrival to ED, NIHSS = 0 and slurred speech had resolved.  CT head was negative.  At 4:45 PM, patient developed sudden left facial droop and slurred speech again. NIHSS = 3 in ED.  Stroke alert called.  No TNKase given outside window from initial symptoms.  CTA head and neck showed no LVO, no ICA stenosis, but noted soft plaque at the right ICA origin without stenosis.   Admitted for acute stroke.  MRI brain showed small volume cortical ischemic infarct at the lower right precentral gyrus. Spoke with Neurology, Dr on 6/8 -- > recommended okay to start apixaban 5 mg BID sometime after 6/11 -- if CT head shows no acute bleed -- for secondary stroke prevention in the setting of new Aflutter.   Notably, patient had new atrial flutter with slowed ventricular response and bradycardia to the 20s to 30s and 4-6 second pauses intermittently (mostly while sleeping) throughout admission.  Asymptomatic throughout admission.  TTE showed improved EF from prior but severely dilated left atrium. Cardiology consulted and recommended holding nodal blockers and no indication for pacemaker. Discussed again with Cards Dr. on 6/9; says he no longer needs to see the patient, and patient is stable for discharge home from his perspective. Said pauses of up to 5 seconds were acceptable as long as asymptomatic. Recommended to discharge with Ziopatch to monitor persistence of the bradycardia and f/u with home Cardiologist. Recommended okay to stop Plavix from cardiac perspective, but should continue aspirin with anticoagulation long-term.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Carotid arteriosclerosis, Cerebrovascular accident, Computerised tomogram head normal, Dizziness, Dysarthria
Clinical narrative: 69-year-old male with history of CAD s/p MI 6/2/2022 (unable to stent LAD -- recommended DAPT for one year, then aspirin only), HFrEF (last EF 30%), HTN, CKD 3, OSA on CPAP, hypothyroidism, who presented with acute onset lightheadedness and slurred speech while exerting himself on a ladder at 12PM on 6/7.  On arrival to ED, NIHSS = 0 and slurred speech had resolved.  CT head was negative.  At 4:45 PM, patient developed sudden left facial droop and slurred speech again. NIHSS = 3 in ED.  Stroke alert called.  No TNKase given outside window from initial symptoms.  CTA head and neck showed no LVO, no ICA stenosis, but noted soft plaque at the right ICA origin without stenosis.   Admitted for acute stroke.  MRI brain showed small volume cortical ischemic infarct at the lower right precentral gyrus. Spoke with Neurology, Dr on 6/8 -- > recommended okay to start apixaban 5 mg BID sometime after 6/11 -- if CT head shows no acute bleed -- for secondary stroke prevention in the setting of new Aflutter.   Notably, patient had new atrial flutter with slowed ventricular response and bradycardia to the 20s to 30s and 4-6 second pauses intermittently (mostly while sleeping) throughout admission.  Asymptomatic throughout admission.  TTE showed improved EF from prior but severely dilated left atrium. Cardiology consulted and recommended holding nodal blockers and no indication for pacemaker. Discussed again with Cards Dr. on 6/9; says he no longer needs to see the patient, and patient is stable for discharge home from his perspective. Said pauses of up to 5 seconds were acceptable as long as asymptomatic. Recommended to discharge with Ziopatch to monitor persistence of the bradycardia and f/u with home Cardiologist. Recommended okay to stop Plavix from cardiac perspective, but should continue aspirin with anticoagulation long-term.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram abnormal, Facial paralysis, Ischaemic cerebral infarction, Left atrial dilatation, Magnetic resonance imaging head abnormal
Clinical narrative: 69-year-old male with history of CAD s/p MI 6/2/2022 (unable to stent LAD -- recommended DAPT for one year, then aspirin only), HFrEF (last EF 30%), HTN, CKD 3, OSA on CPAP, hypothyroidism, who presented with acute onset lightheadedness and slurred speech while exerting himself on a ladder at 12PM on 6/7.  On arrival to ED, NIHSS = 0 and slurred speech had resolved.  CT head was negative.  At 4:45 PM, patient developed sudden left facial droop and slurred speech again. NIHSS = 3 in ED.  Stroke alert called.  No TNKase given outside window from initial symptoms.  CTA head and neck showed no LVO, no ICA stenosis, but noted soft plaque at the right ICA origin without stenosis.   Admitted for acute stroke.  MRI brain showed small volume cortical ischemic infarct at the lower right precentral gyrus. Spoke with Neurology, Dr on 6/8 -- > recommended okay to start apixaban 5 mg BID sometime after 6/11 -- if CT head shows no acute bleed -- for secondary stroke prevention in the setting of new Aflutter.   Notably, patient had new atrial flutter with slowed ventricular response and bradycardia to the 20s to 30s and 4-6 second pauses intermittently (mostly while sleeping) throughout admission.  Asymptomatic throughout admission.  TTE showed improved EF from prior but severely dilated left atrium. Cardiology consulted and recommended holding nodal blockers and no indication for pacemaker. Discussed again with Cards Dr. on 6/9; says he no longer needs to see the patient, and patient is stable for discharge home from his perspective. Said pauses of up to 5 seconds were acceptable as long as asymptomatic. Recommended to discharge with Ziopatch to monitor persistence of the bradycardia and f/u with home Cardiologist. Recommended okay to stop Plavix from cardiac perspective, but should continue aspirin with anticoagulation long-term.
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Respiratory failure
Clinical narrative: CHRONIC HYPERCAPNIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE HYPOXIA
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 1/4/21 lot# 039K20A;  Moderna 2/1/21 lot# 012L20A;  Moderna 11/10/21 lot# 013F21A;
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 1/21/21 lot# EL9261;  Pfizer 3/13/21 lot# EN6200;  Pfizer 8/26/21 lot# FC3182;
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Breast cellulitis, Complication associated with device, Computerised tomogram head normal, Imaging procedure, Meningomyelocele
Clinical narrative: Brief neurosurgery consult note   History:  34 yo woman with extensive VP shunt history, myelomeningocele now with cellulitis over her right breast overlying shunt tubing. I reviewed imaging and it appears that cellulitis is involving old shunt catheter on the right side, potentially tracking up from its origin in the pelvis. Patient is at neurological baseline, head CT and shunt series appear stable on my review. No fevers. WBC elevated.    A/P: 34 yo woman, myelo, vp shunt, cellulitis overlying old right shunt catheter. Potentially tracking from pelvis.  -recommend evaluation and treatment of cellulitis -recommend evaluation by general surgery given fluid collection in pelvis  -no immediate plans for shunt externalization or revision given patient does not have any signs of shunt failure or infection
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pelvic fluid collection, White blood cell count increased
Clinical narrative: Brief neurosurgery consult note   History:  34 yo woman with extensive VP shunt history, myelomeningocele now with cellulitis over her right breast overlying shunt tubing. I reviewed imaging and it appears that cellulitis is involving old shunt catheter on the right side, potentially tracking up from its origin in the pelvis. Patient is at neurological baseline, head CT and shunt series appear stable on my review. No fevers. WBC elevated.    A/P: 34 yo woman, myelo, vp shunt, cellulitis overlying old right shunt catheter. Potentially tracking from pelvis.  -recommend evaluation and treatment of cellulitis -recommend evaluation by general surgery given fluid collection in pelvis  -no immediate plans for shunt externalization or revision given patient does not have any signs of shunt failure or infection
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dysarthria, Neuropathy peripheral, Obstructive sleep apnoea syndrome
Clinical narrative: Moderna vaccine was administered outside - reported by patient ? NO LOT NUMBER WERE SUPPLIED -------------------------------------------------------------------------------------------------------- G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE 3/24/2023 SLURRED SPEECH G62.9 PERIPHERAL NEUROPATHY 4/3/2023 SLURRED SPEECH
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received a second dose of Moderna Bivalent today and after inquiring with data it was noted she received a dose on 10/17/22 at a pharmacy per family member. No adverse reaction noted.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Gastrointestinal haemorrhage, Hypotension, Hypoxia, Respiratory failure
Clinical narrative: Moderna vaccine was administered outside of clinic- reported by patient ? NO LOT NUMBER WERE SUPPLIED ------------------------------------------------------------------------------------------------------------------------- HYPOTENSION 3/31/2023 GI HEMORRHAGE CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/31/2023 GI HEMORRHAGE HYPOXIA 4/21/2023 GI HEMORRHAGE
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 4/1/21 lot# Ew0153;  Pfizer 5/2/21 lot@ Ew0176;  Pfizer 12/17/21 lot# FJ8757
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 43.0
Sex: F
Vaccine: HEPAB
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received her 3rd dose of TwinRix, just 1 month after her 2nd dose given 5-8-2023
Age: 52.0
Sex: F
Vaccine: DTAP
Symptoms: Breast mass, Mammogram, Vaginal disorder
Clinical narrative: I don't know the exact DTAP, you would have to get with the doctor for all of that information.   I had my yearly physical in August and everything was fine.  I got the DTap that day and within a month or 2 I had lumps in my breast and lumps in my vagina.  The only thing that changed was the vaccine.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Pulmonary embolism, Symptom recurrence
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM 12/15/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Janssen 3/16/21 lot# 1802068;  Janssen 11/13/21 lot# 213D21A
Age: 1.08
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, Underdose
Clinical narrative: Patient was here for a nurse care for their second dose of Moderna bivalent vaccine. She was given 0.2ML from the pink cap Moderna vial. She should have received 0.25 ml from the blue cap Moderna vial. She will need one repeat dose of 0.25 ml from the blue cap vial Moderna vaccine to complete her series.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Janssen 3/18/21 lot# 1802068;  Pfizer 11/18/21 Lot# 320308D
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines  Moderna 3/13/21 lot# 044A21A;  Moderna 4/0/21 lot# 018B21A;  Moderna 12/8/21 ot# 030H21B
Age: 53.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Body temperature increased, COVID-19 pneumonia, Chest X-ray, Exposure to SARS-CoV-2
Clinical narrative: 54 yo female with PMHx of cerebral palsy, spastic quadriplegia, traumatic brain injury, presence of PEG tube, admitted on 6/2/23 with acute hypoxemic respiratory failure 2/2 to COVID pneumonia, with ICU stay 6/3-6/7 for hypotension, transferred to medicine floor for on going care.      HPI on admission:    Per Dr.     Patient is a 54 Y  female with a history of spastic quadriplegic cerebral palsy, traumatic brain injury, presence of PEG tube presents to the emergency department from a nursing facility with onset of hypoxia.  History was obtained by ER provider as patient unable to provide history.  Patient was noted to be hypoxic with O2 sat in the low 80s on room air.  There is a COVID outbreak at her boarding care facility.   ER course: Basic labs, chest x-ray, cefepime x1, steroid x1, isolation, oxy mask. Temp of 100.4
Age: 53.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension, Hypoxia, Intensive care, Laboratory test
Clinical narrative: 54 yo female with PMHx of cerebral palsy, spastic quadriplegia, traumatic brain injury, presence of PEG tube, admitted on 6/2/23 with acute hypoxemic respiratory failure 2/2 to COVID pneumonia, with ICU stay 6/3-6/7 for hypotension, transferred to medicine floor for on going care.      HPI on admission:    Per Dr.     Patient is a 54 Y  female with a history of spastic quadriplegic cerebral palsy, traumatic brain injury, presence of PEG tube presents to the emergency department from a nursing facility with onset of hypoxia.  History was obtained by ER provider as patient unable to provide history.  Patient was noted to be hypoxic with O2 sat in the low 80s on room air.  There is a COVID outbreak at her boarding care facility.   ER course: Basic labs, chest x-ray, cefepime x1, steroid x1, isolation, oxy mask. Temp of 100.4
Age: 4.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received incorrect covid vaccine. Patient received dark pink cap with yellow box moderna Lot # 216K22A. Should have received dark blue cap and label moderna
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines  Moderna 2/23/21 lot# 023M20A;  Moderna 3/23/21 lot# 047A21A;  Moderna 11/4/21 lot# 939903;  Moderna 8/24/22 lot# 055A22A
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI ACUTE MI
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 2/27/21 lot# EL3248;  Pfizer 3/20/21 lot# EL9265;  Pfizer 12/16/21 lot# 33130BA
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia, Myocardial ischaemia, Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA DEMAND ISCHEMIA ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 2.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, Underdose
Clinical narrative: Patient was here for a nurse care visit for their COVID (Moderna) vaccine. They had received a Moderna Monovalent vaccine in March of 2023. At their May appointment they were given 0.2ml from the pink cap Moderna vial which was incorrect. They should have received a 0.25 ml dose from the blue cap Moderna vial.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines  Moderna 2/15/21 lot# 031L20A;  Moderna 3/15/21 lot# 030A21A;  Moderna 3/7/22 lot# 016J212A
Age: 32.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site erythema, Injection site pruritus, Vaccination site rash
Clinical narrative: Rash and redness were observed in the vaccine administration area as soon as he was vaccinated. Patient verbalized felt itching in the vaccine administration area. 1ml IM (Diphenhydramine Hydrochloride 50mg/ml) was administered under aseptic measures in the right buttock, according to medical order.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after one dose Janssen
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood test abnormal, Pain, Rheumatoid arthritis, Rheumatoid factor positive
Clinical narrative: Pt. developed pain in the weeks following the administration of of his second Moderna Bivalent Booster. Pt. stated that he then went in for blood work and was diagnosed with rheumatoid arthritis with no prior history of this disease.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy
Clinical narrative: LEFT BELLS PALSY
Age: 12.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site discomfort, Injection site rash, Injection site warmth
Clinical narrative: TWO DAYS AFTER VACCINE WAS ADMINISTERED, PT PRESENTS WITH RASH TO SITE. C/O WARMTH AND DISCOMFORT TO SITE. SYMPTOMS ARE LOCALIZED TO AREA OF ARM VACCINE WAS GIVEN. MOM ADVISED TO TREAT SYMPTOMS (TYLENOL, ICE, TOPICAL BENADRYL, ETC.). ADVISED TO GO TO ER FOR SOB, SWELLING OF FACE OR TONGUE.
Age: 3.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, Underdose
Clinical narrative: Patient came in for yearly check and parent wanted to give the Moderna Covid vaccine this was the patient's first dose. The dose that was given was 0.2 mL from the vial with the pink cap which was the bivalent dose. That was also the only vial we had for the 6month-5year age group. the patient should've been given 0.25 mL from adult via.
Age: 17.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Feeling abnormal, Hypotension, Loss of consciousness, Nausea, Pallor
Clinical narrative: Patient received vaccines x2 in RIGHT arm via injection by MA. After administered, patient began to zone out and brief LOC. Easily aroused. N/V, low BP noted. Ice packs applied, monitored BP. As BP increased, patient's color returned. Patient was A&O x4 upon leaving clinic via wheelchair. Parent drove patient home.  All resolved within 10 minutes
Age: 17.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Vomiting
Clinical narrative: Patient received vaccines x2 in RIGHT arm via injection by MA. After administered, patient began to zone out and brief LOC. Easily aroused. N/V, low BP noted. Ice packs applied, monitored BP. As BP increased, patient's color returned. Patient was A&O x4 upon leaving clinic via wheelchair. Parent drove patient home.  All resolved within 10 minutes
Age: 0.33
Sex: M
Vaccine: RV1
Symptoms: Incorrect route of product administration
Clinical narrative: Vaccine was given via injection, instead of orally. Patient was monitored for 15 minutes in the clinic as part of routine monitoring after vaccination.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Communication disorder, Loss of consciousness, Presyncope
Clinical narrative: Patient had vasovagal episode, losing consciousness for a few seconds. Patient became conscious quickly but remained uncommunicative for an extended period. It took over 30 minutes for patient to feel better. Did walk out of office with mom and sister
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ageusia, COVID-19, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: 12/18/2022 I had a runny nose all day, then towards the end of the day I got a sore throat, and 99-degree fever that evening for maybe an hour.  12/21/2022 I went out to eat and couldn?t taste the food.  Took and At Home COVID-19 Test, positive. Loss of taste lasted about 3 days. Reached out to doctor by email and didn?t hear back.  12/23/2022 I had a little bit of a sore throat in the evening.  I stated home for the next 2 weeks and didn?t notice symptoms.   Late January of 2023 I noticed a ringing in my ears.  I got into see an audiologist on March 7.  That doctor advised hearing is fine, ringing not related to hearing loss.  Ringing in ears continues to time of reporting.
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Tinnitus
Clinical narrative: 12/18/2022 I had a runny nose all day, then towards the end of the day I got a sore throat, and 99-degree fever that evening for maybe an hour.  12/21/2022 I went out to eat and couldn?t taste the food.  Took and At Home COVID-19 Test, positive. Loss of taste lasted about 3 days. Reached out to doctor by email and didn?t hear back.  12/23/2022 I had a little bit of a sore throat in the evening.  I stated home for the next 2 weeks and didn?t notice symptoms.   Late January of 2023 I noticed a ringing in my ears.  I got into see an audiologist on March 7.  That doctor advised hearing is fine, ringing not related to hearing loss.  Ringing in ears continues to time of reporting.
Age: 29.0
Sex: M
Vaccine: VARCEL
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse event. Client had MMR vaccine on 6/7/23. Given another live, varicella vaccine on 6/14/2023
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Rash, Scratch, Skin induration, Skin warm, Underdose
Clinical narrative: Patient developed a rash after being scratched while receiving the MMRV. He pushed the medical assistant's hand away causing a substantial scratch. The remaining amount of vaccine was given 2 cm for the original site. 24 hours later the patient developed a rash that was warm to the touch and slightly hard.  There was no fever or breathing difficulty noted. The patient was seen in office two days after original immunization and it was determined that cephALEXin would be an appropriate treatment.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Menopause, Menstrual disorder
Clinical narrative: My menstrual cycle was three months overdue after receiving the Covid Booster shot when it was a normal cycle like clockwork before even after receiving the first two shots. After receiving the booster my cycle became erratic and I was thrown into perimenopause with terrible symptoms of sudden hot flashes that did not exist before and I feel this is due to the Booster.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia, Amenorrhoea, Anxiety, Condition aggravated, Diarrhoea
Clinical narrative: Hair loss, frequent headaches, body aches, went from regular periods to no periods for 5 months and then extremely painful and heavy menstrual periods lasting anywhere from 3 weeks to 7.5 weeks, Felt internally hot to where I had to lay with ices packs all over my body just to get some relief, shortness of breath, Heart palpitations, increased anxiety and panic attacks, random fevers no higher than 102), Nausea, diarrhea
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysmenorrhoea, Dyspnoea, Feeling hot, Headache, Heavy menstrual bleeding
Clinical narrative: Hair loss, frequent headaches, body aches, went from regular periods to no periods for 5 months and then extremely painful and heavy menstrual periods lasting anywhere from 3 weeks to 7.5 weeks, Felt internally hot to where I had to lay with ices packs all over my body just to get some relief, shortness of breath, Heart palpitations, increased anxiety and panic attacks, random fevers no higher than 102), Nausea, diarrhea
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Palpitations, Panic attack, Pyrexia
Clinical narrative: Hair loss, frequent headaches, body aches, went from regular periods to no periods for 5 months and then extremely painful and heavy menstrual periods lasting anywhere from 3 weeks to 7.5 weeks, Felt internally hot to where I had to lay with ices packs all over my body just to get some relief, shortness of breath, Heart palpitations, increased anxiety and panic attacks, random fevers no higher than 102), Nausea, diarrhea
Age: 16.0
Sex: M
Vaccine: MENB
Symptoms: Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Lt arm with mod. amount of swelling from elbow to should, warm to touch near injection site, mod of pain to area
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arthralgia, Condition aggravated, Mobility decreased
Clinical narrative: 24 HOURS AFTER RECEIVING THE VACCINE MY LEFT WRIST BECAME INCREDIBLY PAINFUL. IT IS THE SITE OF AN OLD INJURY AND ARTHRITIS. ADDITIONALLY, MANY OF MY OTHER JOINTS BECAME PAINFUL AND MADE IT DIFFICULT TO MOVE ABOUT. AS OF TODAY, JUNE 14. MY SYMPTOMS ARE A LITTLE IMPROVED.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Chronic respiratory failure, Respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 34.0
Sex: M
Vaccine: VARCEL
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse event.  Client had MMR vaccine on 6/7/23. Given another live, varicella vaccine on 6/14/23.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: My symptoms were fever, body aches, and low energy.  I tested positive at home on March 31, 2023.  I had a telehealth visit on the same day I was prescribed Paxlovid.  I started the same day.  By the third day my fever was gone and I was feeling better.  I tested again on day 6 and it was negative.  I feel like I have completely recover and do not have any lingering symptoms.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 19.0
Sex: M
Vaccine: MNQ
Symptoms: Discomfort, Headache
Clinical narrative: Patient received Meningococcal vaccine on 6/2/23. Mom states that patient has had headache and still next x3days (since 6/11/23). She reached out to her pediatrician, who stated that the discomfort may be from an ear infection. As of 6/14/23, the symptoms are continuing and mom fears the vaccine is the problem. Mother has been advised to reach back out to her pediatrician for further evaluation of her son.
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA
Age: 47.0
Sex: F
Vaccine: RAB
Symptoms: Asthenia, Hypoaesthesia, Lymphadenopathy, Muscle twitching, Swelling
Clinical narrative: Twitching around pt's mouth. Started day after vaccination (Day 7 rabies vaccine administered on 6/12/23) and lasted around couple of hours. Pt also reported feeling swollen, puffy and having swollen lymph nodes.  Day after getting Day 3 Rabies vaccine (on 6/8/23), pt. reported numbness of her left check that lasted couple of hours and extreme weakness.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: No symptoms for adverse reactions, advertently given unauthorized Pfizer monovalent.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pain in extremity, Skin warm
Clinical narrative: Red arm and painful hot to touch
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Hypotension, Lymphadenopathy
Clinical narrative: I95.9 HYPOTENSION 3/24/2023 CERVICAL LYMPHADENOPATHY I95.9 HYPOTENSION 3/24/2023 ASTHMA, UNSPECIFIED
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Barrett's oesophagus, Chronic respiratory failure, Hyponatraemia, Hypotension
Clinical narrative: I95.9 HYPOTENSION 4/22/2023 HYPONATREMIA J96.10 CHRONIC RESPIRATORY FAILURE 1/17/2023 HYPONATREMIA I95.9 HYPOTENSION 4/22/2023 BARRETTS ESOPHAGUS J96.10 CHRONIC RESPIRATORY FAILURE 1/17/2023 BARRETTS ESOPHAGUS
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: BRCA2 gene mutation, BRCA2 gene mutation assay, Breast cancer female, Gene mutation identification test positive, Invasive ductal breast carcinoma
Clinical narrative: G62.9 NEUROPATHY 4/14/2023 FEMALE BREAST INFILTRATING DUCTAL CARCINOMA, UNSPECIFIED SITE OF LEFT BREAST G62.9 NEUROPATHY 4/14/2023 BRCA2 GENE MUTATION POSITIVE
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: G62.9 NEUROPATHY 4/14/2023 FEMALE BREAST INFILTRATING DUCTAL CARCINOMA, UNSPECIFIED SITE OF LEFT BREAST G62.9 NEUROPATHY 4/14/2023 BRCA2 GENE MUTATION POSITIVE
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Hypoxia, Symptom recurrence
Clinical narrative: HYPOTENSION HYPOXIA 11/17/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Blood culture positive, COVID-19, Catheter placement, Computerised tomogram thorax abnormal
Clinical narrative: Patient was given 3rd dose of Moderna COVID-19 vaccine, lot #030L20A, on 02/21/2021.   Per medical records "Patient is a 91-year-old male with past medical history AFib, thrombocytopenia hypertension, TIA, Parkinson's, NPH status post shunt placement, CLL presenting with shortness of breath. Patient was encephalopathic upon initial encounter so unable to obtain history. He was intubated for airway protection hypoxia. Found to be positive for COVID 19. CT chest after being placed on mechanical ventilation showed large left-sided pneumothorax and pigtail catheter placed. Patient was hypotensive and required vasopressor support. Ceftriaxone was started for possible UTI. Decadron and remdesivir started for COVID. Blood cultures 2/4 are growing Gram-positive cocci in pairs and clusters, vancomycin started. Patient currently off pressors and off mechanical ventilation. 4 L oxygen requirement at this point in time. Transferred to step-down. Cardiology consulted for paroxysmal atrial fibrillation. Seen by speech therapy for oropharyngeal dysphagia. General surgery consulted for PEG tube placement and successful placed on 1/10. He developed worsening hypoxia on 1/12. Family decided on comfort care. He expired on 1/12. Time of death 10:47 AM."
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Dysphagia, Dyspnoea, Encephalopathy
Clinical narrative: Patient was given 3rd dose of Moderna COVID-19 vaccine, lot #030L20A, on 02/21/2021.   Per medical records "Patient is a 91-year-old male with past medical history AFib, thrombocytopenia hypertension, TIA, Parkinson's, NPH status post shunt placement, CLL presenting with shortness of breath. Patient was encephalopathic upon initial encounter so unable to obtain history. He was intubated for airway protection hypoxia. Found to be positive for COVID 19. CT chest after being placed on mechanical ventilation showed large left-sided pneumothorax and pigtail catheter placed. Patient was hypotensive and required vasopressor support. Ceftriaxone was started for possible UTI. Decadron and remdesivir started for COVID. Blood cultures 2/4 are growing Gram-positive cocci in pairs and clusters, vancomycin started. Patient currently off pressors and off mechanical ventilation. 4 L oxygen requirement at this point in time. Transferred to step-down. Cardiology consulted for paroxysmal atrial fibrillation. Seen by speech therapy for oropharyngeal dysphagia. General surgery consulted for PEG tube placement and successful placed on 1/10. He developed worsening hypoxia on 1/12. Family decided on comfort care. He expired on 1/12. Time of death 10:47 AM."
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Endotracheal intubation, Gastrostomy, Gram stain positive, Hypotension, Hypoxia
Clinical narrative: Patient was given 3rd dose of Moderna COVID-19 vaccine, lot #030L20A, on 02/21/2021.   Per medical records "Patient is a 91-year-old male with past medical history AFib, thrombocytopenia hypertension, TIA, Parkinson's, NPH status post shunt placement, CLL presenting with shortness of breath. Patient was encephalopathic upon initial encounter so unable to obtain history. He was intubated for airway protection hypoxia. Found to be positive for COVID 19. CT chest after being placed on mechanical ventilation showed large left-sided pneumothorax and pigtail catheter placed. Patient was hypotensive and required vasopressor support. Ceftriaxone was started for possible UTI. Decadron and remdesivir started for COVID. Blood cultures 2/4 are growing Gram-positive cocci in pairs and clusters, vancomycin started. Patient currently off pressors and off mechanical ventilation. 4 L oxygen requirement at this point in time. Transferred to step-down. Cardiology consulted for paroxysmal atrial fibrillation. Seen by speech therapy for oropharyngeal dysphagia. General surgery consulted for PEG tube placement and successful placed on 1/10. He developed worsening hypoxia on 1/12. Family decided on comfort care. He expired on 1/12. Time of death 10:47 AM."
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Mechanical ventilation, Pneumothorax, SARS-CoV-2 test positive
Clinical narrative: Patient was given 3rd dose of Moderna COVID-19 vaccine, lot #030L20A, on 02/21/2021.   Per medical records "Patient is a 91-year-old male with past medical history AFib, thrombocytopenia hypertension, TIA, Parkinson's, NPH status post shunt placement, CLL presenting with shortness of breath. Patient was encephalopathic upon initial encounter so unable to obtain history. He was intubated for airway protection hypoxia. Found to be positive for COVID 19. CT chest after being placed on mechanical ventilation showed large left-sided pneumothorax and pigtail catheter placed. Patient was hypotensive and required vasopressor support. Ceftriaxone was started for possible UTI. Decadron and remdesivir started for COVID. Blood cultures 2/4 are growing Gram-positive cocci in pairs and clusters, vancomycin started. Patient currently off pressors and off mechanical ventilation. 4 L oxygen requirement at this point in time. Transferred to step-down. Cardiology consulted for paroxysmal atrial fibrillation. Seen by speech therapy for oropharyngeal dysphagia. General surgery consulted for PEG tube placement and successful placed on 1/10. He developed worsening hypoxia on 1/12. Family decided on comfort care. He expired on 1/12. Time of death 10:47 AM."
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION
Age: 54.0
Sex: M
Vaccine: MENB, PNC20, VARZOS
Symptoms: Body temperature increased, Injection site pain, Pain
Clinical narrative: 101.9 temperature for ~36 hours; body aches, severe pain in left arm at injection site (Prevnar 20 and meningococcal group B) for ~72 hours; began 7-day course of amoxicillin
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: No adverse events, inadvertently administered unauthorized Pfizer Monovalent.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: STABLE ANGINA
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Aortic aneurysm, Coagulopathy
Clinical narrative: D68.9 COAGULOPATHY, UNSPECIFIED TYPE 3/31/2023 AORTIC ANEURYSM, UNSPECIFIED SITE
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Sepsis
Clinical narrative: J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/26/2023 SEPSIS UNSPECIFIED ORGANISM
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Neuropathy peripheral, Obstructive sleep apnoea syndrome, Sleep apnoea syndrome
Clinical narrative: SLEEP APNEA OBSTRUCTIVE SLEEP APNEA PERIPHERAL NEUROPATHY
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Respiratory failure, Urinary tract infection
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/28/2023 UTI (URINARY TRACT INFECTION)
Age: 65.0
Sex: M
Vaccine: PNC20
Symptoms: Bacterial infection, Blood test abnormal, Breast abscess
Clinical narrative: Patient developed abscess on left breast 3 days after vaccine.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Symptom recurrence
Clinical narrative: ACUTE NON ST ELEVATION MI 1/1/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Bronchial hyperreactivity, Obstructive sleep apnoea syndrome
Clinical narrative: G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE 5/1/2023 ACUTE RESPIRATORY FAILURE    REACTIVE AIRWAY DISEASE, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 4/14/2023 ACUTE RESPIRATORY FAILURE    REACTIVE AIRWAY DISEASE, UNSPECIFIED J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/14/2023 ACUTE RESPIRATORY FAILURE    REACTIVE AIRWAY DISEASE, UNSPECIFIED
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19-2
Symptoms: Acute myocardial infarction
Clinical narrative: 1) The day after the October dose, the patient was hospitalized with a NSTEMI. 2) 6 days after the June dose the patient was hospitalized with a NSTEMI.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE ST ELEVATION MI, UNSPECIFIED ACUTE NON ST ELEVATION MI 12/27/2022,  11/16/2022,  11/20/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Transient ischaemic attack
Clinical narrative: G45.9 TRANSIENT CEREBRAL ISCHEMIA 4/24/2023 NUMBNESS AND TINGLING OF SKIN
Age: 61.0
Sex: U
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was administered the bivalent vaccine as their first vaccine instead of monovalent.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Respiratory failure, Symptom recurrence
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC RESPIRATORY FAILURE HYPOXIA 1/2/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 0.67
Sex: F
Vaccine: RV5
Symptoms: Extra dose administered
Clinical narrative: Patient given first dose Rotavirus vaccine on 4/3/2023. Patient moved from state. Rotavirus vaccine given in another state.  No prior records of vaccines available.
Age: 59.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cerebrovascular accident
Clinical narrative: ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, MMRV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Mother of patient called the clinic on 6/14 to report swelling and redness at the site of injection
Age: 59.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cardiogenic shock, Symptom recurrence
Clinical narrative: CARDIOGENIC SHOCK 12/8/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 11.0
Sex: U
Vaccine: MMR
Symptoms: Expired product administered
Clinical narrative: Vaccine administered that expired 2/26/2023, Merck notified
Age: 6.0
Sex: F
Vaccine: DTAPHEPBIP, HEPA, MMRV
Symptoms: Rash, Respiratory tract congestion
Clinical narrative: Mother of patient called clinic on 6/13 to report patient was experiencing congestion and rash
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, Respiratory failure
Clinical narrative: J96.00 ACUTE RESPIRATORY FAILURE 4/3/2023 ACUTE RESPIRATORY FAILURE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/25/2023 ACUTE RESPIRATORY FAILURE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 5/3/2023 ACUTE RESPIRATORY FAILURE J96.00 ACUTE RESPIRATORY FAILURE 4/3/2023 ATRIAL FIBRILLATION, UNSPECIFIED J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/25/2023 ATRIAL FIBRILLATION, UNSPECIFIED J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 5/3/2023 ATRIAL FIBRILLATION, UNSPECIFIED
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain in extremity
Clinical narrative: Soar arm
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardioversion, Echocardiogram, Scan myocardial perfusion
Clinical narrative: Have AFIB now, and for 5o years never had this issue.
Age: 18.0
Sex: M
Vaccine: UNK
Symptoms: No adverse event
Clinical narrative: NO ADVERSE ENENTS OR TX WAS NEEDED.  NO S/S OF ANY ALLERGIC OR ADVERSE EFFECT FROM SHOT.